367 related articles for article (PubMed ID: 25607903)
21. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
[TBL] [Abstract][Full Text] [Related]
22. The role of systemic treatments for skin lightening.
Juhasz MLW; Levin MK
J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind, split-face study comparing the efficacy and tolerability of three retinol-based products vs. three tretinoin-based products in subjects with moderate to severe facial photodamage.
Babcock M; Mehta RC; Makino ET
J Drugs Dermatol; 2015 Jan; 14(1):24-30. PubMed ID: 25607905
[TBL] [Abstract][Full Text] [Related]
24. A double-blind randomized study comparing the association of Retinol and LR2412 with tretinoin 0.025% in photoaged skin.
Bouloc A; Vergnanini AL; Issa MC
J Cosmet Dermatol; 2015 Mar; 14(1):40-6. PubMed ID: 25603890
[TBL] [Abstract][Full Text] [Related]
25. In Vitro and In Vivo Efficacy and Tolerability of a Non-Hydroquinone, Multi-Action Skin Tone Correcting Cream.
Grimes PE; McDaniel DH; Wortzman M; Nelson D
J Drugs Dermatol; 2019 Jul; 18(7):642-648. PubMed ID: 31329402
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy evaluation of tretinoin cream 0.02% for the reduction of photodamage: a pilot study.
Kircik LH
J Drugs Dermatol; 2012 Jan; 11(1):83-90. PubMed ID: 22206082
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial.
Kang S; Bergfeld W; Gottlieb AB; Hickman J; Humeniuk J; Kempers S; Lebwohl M; Lowe N; McMichael A; Milbauer J; Phillips T; Powers J; Rodriguez D; Savin R; Shavin J; Sherer D; Silvis N; Weinstein R; Weiss J; Hammerberg C; Fisher GJ; Nighland M; Grossman R; Nyirady J
Am J Clin Dermatol; 2005; 6(4):245-53. PubMed ID: 16060712
[TBL] [Abstract][Full Text] [Related]
28. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies.
Breathnach AS
Cutis; 1996 Jan; 57(1 Suppl):36-45. PubMed ID: 8654129
[TBL] [Abstract][Full Text] [Related]
29. A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage.
Kang S; Krueger GG; Tanghetti EA; Lew-Kaya D; Sefton J; Walker PS; Gibson JR;
J Am Acad Dermatol; 2005 Feb; 52(2):268-74. PubMed ID: 15692472
[TBL] [Abstract][Full Text] [Related]
30. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients.
Bulengo-Ransby SM; Griffiths CE; Kimbrough-Green CK; Finkel LJ; Hamilton TA; Ellis CN; Voorhees JJ
N Engl J Med; 1993 May; 328(20):1438-43. PubMed ID: 8479462
[TBL] [Abstract][Full Text] [Related]
31. Blockade of melanin synthesis, activation and distribution pathway by a nonprescription natural regimen is equally effective to a multiple prescription-based therapeutic regimen.
Thornfeldt C; Rizer RL; Trookman NS
J Drugs Dermatol; 2013 Dec; 12(12):1449-54. PubMed ID: 24301247
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
[TBL] [Abstract][Full Text] [Related]
33. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
Rendon M; Dryer L
J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
[TBL] [Abstract][Full Text] [Related]
34. Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies.
Nyirady J; Bergfeld W; Ellis C; Levine N; Savin R; Shavin J; Voorhees JJ; Weiss J; Grossman R
Cutis; 2001 Aug; 68(2):135-42. PubMed ID: 11534915
[TBL] [Abstract][Full Text] [Related]
35. Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage.
Rafal ES; Griffiths CE; Ditre CM; Finkel LJ; Hamilton TA; Ellis CN; Voorhees JJ
N Engl J Med; 1992 Feb; 326(6):368-74. PubMed ID: 1729619
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of novel topical pigment-correcting regimen with biweekly diamond tip microdermabrasion procedures on facial hyperpigmentation.
Goberdhan L; Schneider K; Makino ET; Bautista A; Mehta RC
J Cosmet Dermatol; 2024 May; 23(5):1726-1733. PubMed ID: 38288515
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of D-pigment dermocosmetic lightening product for solar lentigo lesions of the hand: A randomized controlled trial.
Arginelli F; Greco M; Ciardo S; Josse G; Rossi AB; Le Digabel J; Questel E; Chester J; Pellacani G
PLoS One; 2019; 14(5):e0214714. PubMed ID: 31042723
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
[TBL] [Abstract][Full Text] [Related]
39. New and experimental treatments of cloasma and other hypermelanoses.
Picardo M; Carrera M
Dermatol Clin; 2007 Jul; 25(3):353-62, ix. PubMed ID: 17662901
[TBL] [Abstract][Full Text] [Related]
40. Natural ingredients for darker skin types: growing options for hyperpigmentation.
Alexis AF; Blackcloud P
J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s123-7. PubMed ID: 24002160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
